Alcon said the Aerie deal is another example of its strategy to expand in the ophthalmic pharmaceutical eye drop space. "Aerie is a natural fit with on-market and pipeline products, and R&D ...

Alcon (ALC) announced the U.S. launch of SYSTANE PRO Preservative-Free PF as the latest over-the-counter eye drop in the company’s dry eye portfolio. SYSTANE PRO PF is the longest lasting eye ...

Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

Terms of the deal weren't disclosed. Aurion will operate as a separate company from Alcon, whose products include contact lenses and eye drops. The deal will also see Arnaud Lacoste, who most ...

GENEVA--(BUSINESS WIRE)--Alcon ... eye care dedicated to helping people see brilliantly, today announced the U.S. launch of SYSTANE ® PRO Preservative-Free (PF) as the latest over-the-counter eye ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed. Aurion will operate as ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of SYSTANE® PRO Preservative-Free (PF) as the latest over-the ...

the EX-PRESS ® Glaucoma Filtration Device and pharmaceutical drops. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years ...

Alcon’s advanced lenses, including toric and multi-focal modalities, continue to gain market share. Ocular Health continues to report strong performance with its portfolio of eye drops ...